Silverwood Partners
  • About Us
    • Overview
    • Why Silverwood?
    • Careers
    • Our Location
    • Connect With Us
  • Insights & Analysis
    • Newsletters
    • Intelligence Briefs
    • Events
    • Connect With Us
  • Team
    • All Team
    • Technology
    • Consumer
    • Healthcare
  • Industry Experience
    • Technology
    • Consumer
    • Healthcare
    • Connect With Us
  • Services
    • Mergers & Acquisitions
    • Private Placements
    • Connect With Us
  • Transactions
    • All Transactions
    • Technology
    • Consumer
    • Healthcare
    • Connect With Us
Select Page
Healthcare Private Placement and M&A Transactions Review Week Ending April 23, 2023

Healthcare Private Placement and M&A Transactions Review Week Ending April 23, 2023

by Jonathan Hodson-Walker | Apr 26, 2023 | Healthcare

Strategy | Financing Highlight  Private Placement / Financing Transactions Distalmotion: The company raised $150 million of venture funding in a deal led by Revival Healthcare Capital on April 19, 2023. Other undisclosed investors also participated in the round. The...
Healthcare Private Placement and M&A Transactions Review Week Ending April 16, 2023

Healthcare Private Placement and M&A Transactions Review Week Ending April 16, 2023

by Jonathan Hodson-Walker | Apr 20, 2023 | Healthcare

Strategy | Financing Highlight  Private Placement / Financing Transactions TORL BioTherapeutics: The company raised $158 million of Series B venture funding in a deal led by Goldman Sachs Asset Management April 13, 2023. Moore Strategic Ventures and 7 other investors...
Healthcare Private Placement and M&A Transactions Review Week Ending April 9, 2023

Healthcare Private Placement and M&A Transactions Review Week Ending April 9, 2023

by Jonathan Hodson-Walker | Apr 13, 2023 | Healthcare

Strategy | Financing Highlight  Private Placement / Financing Transactions Mercy BioAnalytics: The company raised $41 million of Series A venture funding in a deal led by Novalis LifeSciences on April 3, 2023, putting the company’s pre-money valuation at $81...
Healthcare Private Placement and M&A Transactions Review Week Ending April 2, 2023

Healthcare Private Placement and M&A Transactions Review Week Ending April 2, 2023

by Jonathan Hodson-Walker | Apr 5, 2023 | Healthcare

Strategy | Financing Highlight  Private Placement / Financing Transactions ArriVent Biopharma: The company raised $155 million of Series B venture funding in a deal led by Sofinnova Investments and General Catalyst on March 27, 2023, putting the company’s...
Healthcare Private Placement and M&A Transactions Review Week Ending March 26 2023

Healthcare Private Placement and M&A Transactions Review Week Ending March 26 2023

by Jonathan Hodson-Walker | Mar 29, 2023 | Healthcare

Strategy | Financing Highlight  Private Placement / Financing Transactions Flare Therapeutics: The company raised $123 million of Series B venture funding in a deal led by Pfizer Ventures and GordonMD Global Investments on March 22, 2023, putting the company’s...
Healthcare Private Placement and M&A Transactions Review Week Ending March 19 2023

Healthcare Private Placement and M&A Transactions Review Week Ending March 19 2023

by Jonathan Hodson-Walker | Mar 21, 2023 | Healthcare

Strategy | Financing Highlight  Private Placement / Financing Transactions Mediar Therapeutics: The company raised $85 million of Series A venture funding in a deal led by Novartis Venture Fund and Sofinnova Partners on March 15, 2023, putting the company’s...
« Older Entries
Next Entries »

Search

Recent Posts

  • Technology Private Placement and M&A Transactions Review Week Ending May 4, 2025
  • Consumer Private Placement and M&A Transactions Review Week Ending May 4, 2025
  • Healthcare Private Placement and M&A Transactions Review Week Ending May 4, 2025
  • Technology Private Placement and M&A Transactions Review Week Ending April 27, 2025
  • Consumer Private Placement and M&A Transactions Review Week Ending April 27, 2025

Categories

Archives